Luke Walters, PA
Medical · Mount Vernon, WANPI 1043577562
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.6% of the total across 259 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 28 manufacturers reported payments, led by AbbVie at 24.8% of the total. 2025 is the largest year on record at $1,925, 6.3 times the $307 reported in 2021. Among medical clinicians in WA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 259 payments — averaging $19.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Novartis$616
- Lilly USA, LLC$403
- Sanofi$381
- E.r. Squibb & Sons, L.L.C.$304
- Regeneron Healthcare Solutions, Inc.$265
- plus $2K from 22 others
What the payments were for
- Food & beverage$4,914100%
- Education$180%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 81 | $1,224 |
| Novartis | 30 | $616 |
| Lilly USA, LLC | 19 | $403 |
| Sanofi | 13 | $381 |
| E.r. Squibb & Sons, L.L.C. | 21 | $304 |
| Regeneron Healthcare Solutions, Inc. | 11 | $265 |
| UCB, Inc. | 9 | $257 |
| Johnson & Johnson | 8 | $211 |
| Pfizer | 12 | $211 |
| LEO Pharma Inc. | 10 | $208 |
| Arcutis Biotherapeutics, Inc. | 6 | $101 |
| Incyte Corporation | 4 | $98 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 5 | $94 |
| Sun Pharmaceutical Industries Inc. | 4 | $81 |
| Amgen | 3 | $66 |
| Kerecis Limited | 2 | $56 |
| Organon | 4 | $53 |
| Mayne Pharma Commercial LLC | 4 | $45 |
| LNHC, Inc | 2 | $45 |
| Smith+Nephew | 1 | $39 |
| Dermavant Sciences, Inc. | 2 | $36 |
| EPI Health, LLC | 2 | $31 |
| Boehringer Ingelheim | 1 | $28 |
| Organogenesis Inc. | 1 | $18 |
| Strata Skin Sciences, Inc. | 1 | $16 |
| Verrica Pharmaceuticals Inc. | 1 | $15 |
| Almirall LLC | 1 | $15 |
| Galderma Laboratories, L.p. | 1 | $14 |
How this compares
$4,932 in reported general payments places this provider in the 90th percentile of 457 medical providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 35 | $195,583 |
| RinvoqUpadacitinib | 24 | $193,167 |
| Taltz AutoinjectorIxekizumab | 21 | $142,658 |
| OtezlaApremilast | 12 | $56,001 |
| Clobetasol Propionate | 126 | $5,171 |
| Tacrolimus | 24 | $4,859 |
| Ketoconazole | 125 | $1,484 |
| Triamcinolone Acetonide | 145 | $1,244 |
| Clindamycin-Benzoyl PeroxideClindamycin Phos/Benzoyl Perox | 14 | $1,188 |
| Fluorouracil | 17 | $1,027 |
| Minoxidil | 58 | $814 |
| Betamethasone Dipropionate | 17 | $738 |
| Doxycycline Hyclate | 37 | $720 |
| Fluocinolone AcetonideFluocinolone/Shower Cap | 11 | $523 |
| Clindamycin Phosphate | 23 | $477 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRinvoq | $1,224 | $193,16724 claims |
| AmgenOtezla | $66 | $56,00112 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 457 medical providers in Washington.
Other medical in Mount Vernon
- Diana McFarlaneSeattle$95K
- Karissa SecoraTacoma$53K
- Tori FranklinLakewood$23K
- Salvador LopezYakima$17K
- Amy NelsonSeattle$15K
- Rebecca JohnsonSpokane$14K
- Jonathan CyphersBurien$13K
- Jonathan WhiteSeattle$13K
- Julia TaylorSpokane$12K
- Kristine WesselsSpokane$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.